Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2006
06/13/2006US7060272 Death domain containing receptor-4 agonist antibodies and methods
06/13/2006US7060269 Anti-VEGF antibodies
06/13/2006US7060265 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
06/13/2006US7060261 Nucleotide sequences coding polypeptide for us ein the treatment of immunological disorders
06/13/2006CA2155434C Prohormone convertase transformed cells and polypeptide synthesis
06/13/2006CA2064761C Methods and compositions for the production of stably transformed fertile monocot plants and cells thereof
06/11/2006CA2526686A1 Expression cassettes for regulating meristem-preferential or meristem-specific expression in plants
06/08/2006WO2006060779A2 Novel methods, compositions and devices for inducing neovascularization
06/08/2006WO2006060193A2 Compositions and methods for stem cell expansion
06/08/2006WO2006060020A1 Sm5-1 antibodies and applications thereof
06/08/2006WO2006059953A1 Culture medium for enhancing hepatic function
06/08/2006WO2006059712A1 Monoclonal antibody binding to human steroid sulfatase
06/08/2006WO2006059626A1 Device for biosample storage
06/08/2006WO2006059529A1 Hla-a24-restricted tumor antigen peptide
06/08/2006WO2006059433A1 Novel anthocyanidin glucosyltransferase gene
06/08/2006WO2006059323A2 Production of proteins
06/08/2006WO2006059130A2 Manipulation of starch granule size and number (ii)
06/08/2006WO2006058427A1 Platelet-derived growth factor-responsive neural precursor cells and progeny thereof
06/08/2006WO2006044842A3 Pancreatic islet beta-cell-like macrophages and methods to produce them
06/08/2006WO2006037657A3 Quadruple transformed cell line useful for the identification of transport inhibitors
06/08/2006WO2006028495A3 Lipases and methods of use
06/08/2006WO2006027229A8 Scalable process for cultivating undifferentiated stem cells in suspension
06/08/2006WO2006017325A3 Aav vector compositions and methods for enhanced expression of immunoglobulins the same
06/08/2006WO2006015209A3 Differentiation of stem cells
06/08/2006WO2006013010A3 Preparation of organisms with faster growth and/or higher yield
06/08/2006WO2006001021A3 Chimeric avian-based screening system containing mammalian grafts
06/08/2006WO2005123908A3 Novel cancer cell lines and uses thereof
06/08/2006WO2005121317A3 Method for obtaining mesenchymal stem cells
06/08/2006WO2005118820A8 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
06/08/2006WO2005118778A8 Method for ex vivo isolating and expanding human cornea stem cells and uses thereof
06/08/2006WO2005092069A3 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
06/08/2006WO2005089043A3 Prostate stem cell
06/08/2006WO2005085423A8 Oct-4 and gjic expression as markers for adult human stem cells and cancer cell precursors
06/08/2006WO2005079204A3 Artificial synapse chip
06/08/2006WO2005053601A3 Methods of generating stem cells and embryonic bodies carrying disease-causing mutations and methods of using same for studying genetic disorders
06/08/2006WO2005047487B1 Motoneuronotrophic factor gene sequences
06/08/2006WO2005010197A3 A systemic small rna signaling system in plants
06/08/2006WO2005002527A3 Sirt1 modulation of adipogenesis and adipose function
06/08/2006US20060123518 Methods for culturing cereal endosperm
06/08/2006US20060123517 For producing a pumpkin plant containing in its genetic material one or more transgenes, higher yield, field performance, fruit and agronomic quality such as smoothness, color, shape and size, flesh color or texture, leaf shape and size, vine length and branching pattern, resistance to diseases
06/08/2006US20060123515 Expression of human interferon in transgenic chloroplasts
06/08/2006US20060123512 novel DNA probes useful in detecting a nucleic acid sequence encoding a novel Lepidopteran- and Coleopteran-active delta -endotoxin polypeptide. Also disclosed are nucleic acid detection methods and kits involving the novel DNA probes.
06/08/2006US20060123510 In a sense or antisense orientation, wherein expression results in production of altered levels of the RNA-directed RNA polymerase in a transformed host cell; vectors, transgenic plants; use as tool to control gene expression via cosuppression and to engineer plant virus resistance
06/08/2006US20060123508 plants with nucleotide sequences coding dihydroflavonol reductase (DFR) for generating transgenic plants with increased carbohydrates and nutritional value and which drecrease bloating in animals
06/08/2006US20060123507 Gene elevating cereal yield and utilization thereof
06/08/2006US20060123505 Full-length plant cDNA and uses thereof
06/08/2006US20060123503 V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto
06/08/2006US20060123501 Method for treating inflammatory disorders
06/08/2006US20060123500 Methods of prescreening cells for nuclear transfer procedures
06/08/2006US20060123497 Sperm-specific cation channel, catsper-4, and uses therefor
06/08/2006US20060123495 Knockout mice and their use
06/08/2006US20060123490 Pluripotent cells with improved efficiency of homologous recombination and use of the same
06/08/2006US20060122695 Tissue Engineered Stents
06/08/2006US20060122381 Recombinase mediated transcription
06/08/2006US20060122376 Protein complexes having factor VIII:C activity and production thereof
06/08/2006US20060122375 Plant stress tolerance genes, and uses therefor
06/08/2006US20060122374 Albumin-fused anti-angiogenesis peptides
06/08/2006US20060122370 Specific binding agents of human angiopoietin-2
06/08/2006US20060122132 Use of murine genomic regions identified to be involved in tumor developement for the development of anti-cancer drugs and diagnosis of cancer
06/08/2006US20060122119 Peptides for use in antitumor immunotherapy
06/08/2006US20060122111 Regeneration and neogenesis of retinal visual cell otx2 gene
06/08/2006US20060122108 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions
06/08/2006US20060122107 Method of modulating cellular activity and molecules for use therein
06/08/2006US20060122104 Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells
06/08/2006US20060121611 Fed-batch process for production of erythropoietin in human embryonic retina cells that express adenovirus E1A
06/08/2006US20060121609 Gradient scaffolding and methods of producing the same
06/08/2006US20060121608 Keratinocytes and culture medium containing ascorbic and linoleic acid, vitamin e, epidermal growth factor; has surface electrical capacitance of given values
06/08/2006US20060121607 Compositions and methods for neural differentiation of embryonic stem cells
06/08/2006US20060121606 Cell culture method and cultured tissue
06/08/2006US20060121605 Selection and propagation of progenitor cells
06/08/2006US20060121579 Regulated nucleic acid expression system
06/08/2006US20060121577 Comprises polynucleotides coding proteins associated with generating macrolide antibiotics; bactericides; polyketide synthase
06/08/2006US20060121575 Methods for increasing the diversity of monoclonal antibodies produced against an antigen
06/08/2006US20060121574 Recombinant method for making multimeric proteins
06/08/2006US20060121569 Providing a cell culture comprising; ammalian cells that contain a gene encoding TNFR-Ig, which gene is expressed under condition of cell culture; medium containing glutamine; maintaining culture in an initial growth phase, changing culture conditions, maintaining culture
06/08/2006US20060121568 Production of polypeptides
06/08/2006US20060121566 Stem cell expansion factor blocking gene limiting hox-induced expansion and method using such factor
06/08/2006US20060121565 Methods for increasing the production of a recombinant polypeptide from a host cell
06/08/2006US20060121564 Novel expression vector suitable for expression of recombinant protein at low temperature
06/08/2006US20060121560 DNA fragment to promote translation reaction and method for cell-free protein synthesis system using the same
06/08/2006US20060121541 Use of endosialin binding proteins to isolate endosialin positive cells
06/08/2006US20060121534 Methods for culturing mammalian taste cells
06/08/2006US20060121514 Prostacyclin-stimulating Factor-2
06/08/2006US20060121512 Biological pathways in progenitor cells
06/08/2006US20060121460 Toll-like receptor 11
06/08/2006US20060121454 diagnosis and treatment of carcinomas, especially breast cancers
06/08/2006US20060121449 Method for selection of compounds which inhibit clonal cell growth and use thereof
06/08/2006US20060121445 Scoring method for determining pancreas suitability for islet isolation
06/08/2006US20060121444 Use of flow-cytrometric analysis to optimize cell banking strategies for CHO cells
06/08/2006US20060121441 Methods of determining the effect of an agent on diploid cells and/or on the pattern of expression of polypeptides expressed therewith
06/08/2006US20060121440 Low pressure sperm cell separation system
06/08/2006US20060121438 Methods and solutions for storing donor organs
06/08/2006US20060121116 Sol-gel chemotaxis induced concentration gradient for separation of cells/organisms within suspensions
06/08/2006US20060121091 Cellular uptake of bioactive agents
06/08/2006US20060121063 Group 2 mite polypeptide variants
06/08/2006US20060121042 Modulation of antibody specificity by tailoring the affinity to cognate antigens
06/08/2006US20060121025 VEGF-related protein
06/08/2006US20060121014 Cell culture comprises astrocytes with induced antioxidant response element (ARE) mediated transcription; Alzheimer's disease, Huntington's disease, Parkinson's disease
06/08/2006US20060121013 Use of negative regulatory elements for the neurospecific expression of transgenes
06/08/2006US20060121012 An implantable device coated with a matrix-bound ligand that binds the cell membrane markers of genetically altered mammalian cells and express and secrete at least one therapeutic gene product; vascular diseases; anticarcinogenic agents